Peter Slavin - American Well Independent Director
| AMWL Stock | USD 9.31 1.21 14.94% |
Insider
Peter Slavin is Independent Director of American Well Corp since 2016.
| Age | 62 |
| Tenure | 8 years |
| Address | 75 State Street, Boston, MA, United States, 02109 |
| Phone | 617 204 3500 |
| Web | https://business.amwell.com |
Peter Slavin Latest Insider Activity
Tracking and analyzing the buying and selling activities of Peter Slavin against American Well stock is an integral part of due diligence when investing in American Well. Peter Slavin insider activity provides valuable insight into whether American Well is net buyers or sellers over its current business cycle. Note, American Well insiders must abide by specific rules, including filing SEC forms every time they buy or sell American Well'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Peter Slavin over a year ago Sale by Peter Slavin of 2330 shares of American WellCorp | ||
Peter Slavin over a year ago Acquisition by Peter Slavin of 91743 shares of American WellCorp subject to Rule 16b-3 | ||
Peter Slavin over a year ago Sale by Peter Slavin of 22670 shares of American WellCorp |
American Well Management Efficiency
The company has return on total asset (ROA) of (0.2542) % which means that it has lost $0.2542 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5015) %, meaning that it created substantial loss on money invested by shareholders. American Well's management efficiency ratios could be used to measure how well American Well manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is expected to rise to -1.37 this year. Return On Capital Employed is expected to rise to -1.33 this year. At this time, American Well's Debt To Assets are quite stable compared to the past year. Asset Turnover is expected to rise to 0.46 this year, although the value of Non Currrent Assets Other will most likely fall to about 4.9 M.Similar Executives
| Showing other executives | INSIDER Age | ||
| Arnnon Geshuri | Teladoc | 54 | |
| Ato Garrett | Veeva Systems Class | N/A | |
| David Linetsky | Phreesia | 43 | |
| Joseph Mirisola | Definitive Healthcare Corp | 40 | |
| Scott Perricelli | Phreesia | 47 | |
| Andrew Schemick | Certara | 50 | |
| Michael Sturmer | Progyny | 47 | |
| Jason Jones | Health Catalyst | N/A | |
| Nate Gross | Doximity | N/A | |
| Pinal Patel | Veeva Systems Class | N/A | |
| Douglas Hirsch | Goodrx Holdings | 53 | |
| Dave Ross | Health Catalyst | N/A | |
| George Brooks | Teladoc | N/A | |
| Hemant Taneja | Teladoc | N/A | |
| Daniel Burton | Health Catalyst | 49 | |
| Ramin Sayar | Phreesia | 47 | |
| Mark Smith | Phreesia | 68 | |
| Jonathan Schimmel | 10X Genomics | N/A | |
| Kate Jensen | Definitive Healthcare Corp | 38 | |
| Gillian Munson | Phreesia | 50 | |
| Serge Saxonov | 10X Genomics | 47 | |
Management Performance
| Return On Equity | -0.5 | ||||
| Return On Asset | -0.25 |
American Well Corp Leadership Team
Elected by the shareholders, the American Well's board of directors comprises two types of representatives: American Well inside directors who are chosen from within the company, and outside directors, selected externally and held independent of American. The board's role is to monitor American Well's management team and ensure that shareholders' interests are well served. American Well's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, American Well's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert Shepardson, Chief Financial Officer | ||
| Tim Conway, Chief Officer | ||
| Paul McNeice, Vice Accounting | ||
| Meredith Dixon, Senior Services | ||
| Amber Howe, Chief People Officer | ||
| MD MPH, CoCEO Pres | ||
| Ido Schoenberg, Chairman of the Board, Co-Chief Executive Officer | ||
| Brendan OGrady, Chief Commercial & Growth Officer | ||
| MD FAAFP, Chief Group | ||
| Peter Slavin, Independent Director | ||
| Kurt Knight, Chief Operating Officer | ||
| Deval Patrick, Independent Director | ||
| Susan Worthy, Chief Officer | ||
| Sue Dooley, Head Relations | ||
| Keith Anderson, Chief Financial Officer | ||
| Serkan Kutan, Chief Technology Officer | ||
| Vukasin Paunovich, Executive Platforms | ||
| Kathy Weiler, Executive Officer | ||
| Nazim Cetin, Independent Director | ||
| Delos Cosgrove, Independent Director | ||
| Mark Hirschhorn, Chief Officer | ||
| Jason Medeiros, Chief Information Officer | ||
| Bradford JD, Senior Counsel | ||
| Ido MD, Chairman CoCEO | ||
| Stephen Schlegel, Independent Director | ||
| Roy Schoenberg, President, Co-Chief Executive Officer, Director | ||
| Deborah Jackson, Independent Director | ||
| Mark CPA, Chief Officer | ||
| Mary Modahl, Chief Marketing Officer | ||
| Bradford Gay, Senior Vice President General Counsel | ||
| Derek Ross, Independent Director | ||
| Phyllis Gotlib, President American Well International | ||
| MPH MD, Executive Chairman |
American Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is American Well a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.5 | ||||
| Return On Asset | -0.25 | ||||
| Profit Margin | (0.84) % | ||||
| Operating Margin | (0.78) % | ||||
| Current Valuation | (111.46 M) | ||||
| Shares Outstanding | 13.67 M | ||||
| Shares Owned By Insiders | 6.35 % | ||||
| Shares Owned By Institutions | 49.28 % | ||||
| Number Of Shares Shorted | 382.05 K | ||||
| Price To Book | 0.37 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in American Well Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of American Well. If investors know American will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about American Well listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (16.61) | Revenue Per Share 17.223 | Quarterly Revenue Growth (0.01) | Return On Assets (0.25) | Return On Equity (0.50) |
The market value of American Well Corp is measured differently than its book value, which is the value of American that is recorded on the company's balance sheet. Investors also form their own opinion of American Well's value that differs from its market value or its book value, called intrinsic value, which is American Well's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because American Well's market value can be influenced by many factors that don't directly affect American Well's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between American Well's value and its price as these two are different measures arrived at by different means. Investors typically determine if American Well is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, American Well's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.